Invitae Corporation

Equities

NVTA.Q

US46185L1035

Biotechnology & Medical Research

End-of-day quote OTC Markets Other stock markets 03:30:00 16/07/2024 am IST			5-day change	1st Jan Change
0.0003 ^USD	-40.00%		-72.73%	-99.95%

13/06	First Amended Disclosure Statement Approved for Invitae Corporation	CI
11/06	Motion for Exclusivity Period Extension Approved For Invitae Corporation	CI

Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023 at 06:01 pm IST

SAN FRANCISCO, Jan. 4, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president & chief executive officer, will present at the 41^st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 12:00 p.m. Eastern / 9:00 a.m. Pacific.

Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)

The live audio webcast of the presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation.

About Invitae

Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information simplified by digital technology. With accurate and actionable answers to strengthen medical decision-making, Invitae gives individuals and their families powerful, personalized insights that could improve and extend their lives. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.

Contacts for Invitae:

Investor Relations
Hoki Luk
ir@invitae.com

Public Relations
Amy Hadsock
pr@invitae.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301712818.html

SOURCE Invitae Corporation

Latest news about Invitae Corporation

First Amended Disclosure Statement Approved for Invitae Corporation	13/06	CI
Motion for Exclusivity Period Extension Approved For Invitae Corporation	11/06	CI
First Amended Joint Liquidation Plan and Disclosure Statement Filed by Invitae Corporation	11/06	CI
North American Morning Briefing : PCE Inflation -2-	28/05	DJ
First Motion for Exclusivity Period Extension Filed by Invitae Corporation	21/05	CI
Joint Liquidation Plan and Disclosure Statement Filed by Invitae Corporation	09/05	CI
Motion for Asset Sale Approved for Invitae Corporation	07/05	CI
Labcorp beats quarterly estimates on strong testing demand	25/04	RE
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	25/04	RE
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	24/04	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation (OTCPK:NVTA.Q).	24/04	CI
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance	11/04	CI
Invitae Launches Update to Invitae Generation: Clinical Variant Modeling Improves Variant Classification	12/03	CI
Earnings Flash (NVTA) INVITAE CORPORATION Posts Q4 Revenue $127.8M	06/03	MT
Invitae Corporation Provides Unaudited Earnings Guidance for the Fourth Quarter and Full Year of 2023	06/03	CI
Bidding Procedure Approved for Invitae Corporation	16/02	CI
Motion for Joint Administration Approved for Invitae Corporation	16/02	CI
Invitae gets court approval for five-month bankruptcy sale	16/02	RE
Global markets live: Airbnb, Sony, Uber, Lyft, Nvidia...	14/02
Genetic test maker Invitae files for bankruptcy protection in US	14/02	RE
Motion for Asset Sale Filed by Invitae Corporation	14/02	CI
Invitae Corporation Lists Estimated Assets In The Range Of $500 Mln -$1 Bln - Court Filing	14/02	RE
INVITAE CORPORATION LISTS ESTIMATED LIABILITIES IN THE RANGE OF…	14/02	RE
Genetic test maker Invitae files for voluntary Chapter 11 protection	14/02	RE
Motion for Joint Administration Filed by Invitae Corporation	13/02	CI

Chart Invitae Corporation

Duration

Period

More charts

Company Profile

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The Company also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The Company has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.

Sector

Biotechnology & Medical Research

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
INVITAE CORPORATION	-99.95%	1L
EXACT SCIENCES CORPORATION	-32.86%	868.21Cr
GUARDANT HEALTH, INC.	+25.06%	385.95Cr
IOVANCE BIOTHERAPEUTICS, INC.	+15.74%	242.89Cr
BGI GENOMICS CO., LTD.	-26.46%	183.93Cr
VERACYTE, INC.	-7.09%	172.7Cr
MARAVAI LIFESCIENCES HOLDINGS, INC.	+40.61%	116.36Cr
CAREDX, INC	+54.75%	84Cr
SEEGENE, INC.	-9.17%	70Cr
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-9.18%	59Cr

Bio Diagnostics & Testing

Invitae Corporation

Equities

NVTA.Q

US46185L1035

Biotechnology & Medical Research

Invitae to Present at the 41st Annual J.P. Morgan Healthcare Conference

Latest news about Invitae Corporation

Chart Invitae Corporation

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Bio Diagnostics & Testing